Free Shipping in the U.S. for orders over $1000.  Shop Now>>

Printable Datasheet

Recombinant Bcl-X (Apoptosis Marker) Antibody [BCL2L1/9221R]

In Stock
Catalog Number Formulation Size Price
598-RBM11-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$249.00
598-RBM11-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$539.00
598-RBM11-P1ABX
Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
100ug
$539.00
Flat Rate Domestic: $75 | Orders outside the US - Contact Us for Order Information | Ships next business day
Recombinant Bcl-X (Apoptosis Marker) Antibody

SDS-PAGE Analysis of Purified Bcl-x Recombinant Rabbit Monoclonal Antibody (BCL2L1/9221R). Confirmation of Purity and Integrity of Antibody.

Recombinant Bcl-X (Apoptosis Marker) Antibody - Image 2

Formalin-fixed, paraffin-embedded human Hodgkin's lymphoma stained with Bcl-x Recombinant Rabbit Monoclonal Antibody (BCL2L1/9221R). HIER: Tris/EDTA, pH9.0, 45min. 2°C: HRP-polymer, 30min. DAB, 5min.

Bcl-X Antibody in Western Blot (WB)

Bcl-X Antibody in Western Blot (WB)

Western Blot Analysis of HeLa, Jurkat, NIH/3T3, Hep G2 and HDLM-2 cell lysates using Bcl-X Recombinant Rabbit Monoclonal Antibody (BCL2L1/9221R).

Bcl-X Antibody in Western Blot (WB)

Bcl-X Antibody in Western Blot (WB)

Western blot analysis of Human Kidney, Mouse Kidney, Rat Kidney, Hamster Kidney and Guinea pig Kidney tissue lysates using Bcl-X Recombinant Rabbit Monoclonal Antibody (BCL2L1/9221R).

Applications & Dilutions

Applications Tested Dillution Protocol Note
Immunohistochemistry (IHC)
1-2ug/ml
IHC Protocol
30 min at RT. Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes
Western Blot (WB)
2-4ug/ml
Western Blot Protocol

Summary

Recognizes a protein of 27kDa, identified as the Bcl-X protein. This MAb shows no cross-reaction with Bcl-2α or Bax protein. Bcl-X has two isoforms, Bcl-XL (long), a 241-amino acid protein which suppresses cell death. And Bcl-XS (short), a 178-amino acid protein lacking a 63-amino acid domain which functions as a dominant inhibitor of Bcl-2.

Product Properties & Targets

Antibody Type
Recombinant Rabbit Monoclonals
Host
Rabbit
Applications
Immunohistochemistry, Western Blot
Species Reactivity
Hamster, Human, Rat
Research Areas
Apoptosis, Autophagy, Cardiovascular, Immunology, Colon Cancer, Cytokine Signaling, Infectious Disease, Lung Cancer, Mitochondria Marker, Signal Transduction
Isotype / Light Chain
IgG / Kappa
Cellular Localization
Cytoplasm. Cell membrane. Nuclear membrane.
Gene Name
BCL2L1
Positive Control
HeLa, Jurkat, NIH/3T3, Hep G2 and HDLM-2, HL-60. Reed-Sternberg cells in Hodgkin s lymphoma.K562, Human Kidney, Rat Kidney or Hamster Kidney
Immunogen
Recombinant fragment (around aa1-100) of human BCL2L1 protein (exact sequence is proprietary)
Alternate Names
Bcl-2-like protein 1, Apoptosis regulator Bcl-X, Apoptosis regulator Bcl-X, B cell lymphoma 2 like, BCL XL/S, Bcl-2-like protein 1, Bcl2-L-1, BCL2L, Bcl2l1, BCLX, BclXL, BclXs, Protein phosphatase 1 regulatory subunit 52 (PPP1R52)

Database Links

Entrez Gene ID
598
SwissProt
Q07817

Additional Information

Clone
BCL2L1/9221R
Chromosome Location
20q11.21
Mol. Weight of Antigen
27kDa

Related Antibodies

View All BCL2L1 Antibodies

Functions

  • Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis.
  • Isoform Bcl-X(L) also regulates presynaptic plasticity, including neurotransmitter release and recovery, number of axonal mitochondria as well as size and number of synaptic vesicle clusters. During synaptic stimulation, increases ATP availability from mitochondria through regulation of mitochondrial membrane ATP synthase F(1)F(0) activity and regulates endocytic vesicle retrieval in hippocampal neurons through association with DMN1L and stimulation of its GTPase activity in synaptic vesicles. May attenuate inflammation impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (PubMed:17418785).
  • Isoform Bcl-X(S) promotes apoptosis.

Key References

  • Hsu YT, et. al. Journal of Biological Chemistry, 1997, 272(21):13829-34.
  • Wolter KG, et. al. Journal of Cell Biology, 1997, 139(5):1281-92.

PubMed Links

Storage & Stability

Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.

Reviews

There are no reviews yet.

Be the first to review “Recombinant Bcl-X (Apoptosis Marker) Antibody”

Your email address will not be published. Required fields are marked *

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK
Call Us Now: 1-866-2-NEOBIO (1-866-263-6246)
NeoBiotechnologies Logo
Company Info
Antibodies
Antibody Validation
Research Areas
Resources
Newsletter Signup Updates & Sales